Jump to content

Alkem Laboratories

Edit links
From Wikipedia, the free encyclopedia

Alkem Laboratories Limited
Company typePublic
BSE: 539523
NSE: ALKEM
IndustryPharmaceuticals
Founded1973
FounderSamprada Singh[1]
Headquarters
Mumbai, Maharashtra
,
India
ProductsPharmaceuticals, generic drugs, over-the-counter drugs, vaccines, diagnostics, contact lenses, animal health
RevenueIncrease ₹10,634 crore (US$1.2 billion) (2024)[2]
Increase ₹2,052 crore (US$240 million) (2022)[2]
Increase ₹1,645 crore (US$190 million) (2024)[2]
Total assetsIncrease ₹14,069 crore (US$1.6 billion) (2024)[2]
Total equityIncrease ₹8,637 crore (US$1.0 billion) (2024)[2]
OwnerThe Singh Family
Number of employees
20,000 (2024)[2]
SubsidiariesPharmacor Limited, Ascend, Cachet, Enzene, Indchemie, Connect2clinic, Alkem Foundation[3]
Websitewww.alkemlabs.com

Alkem Laboratories Limited is a leading Indian multinational pharmaceutical company headquartered in Mumbai,India. Specialising in generics and speciality pharmaceuticals, Alkem manufactures and markets a diverse portfolio of pharmaceutical generics, formulations and nutraceuticals across India and global markets.

With over five decades of expertise in the pharmaceutical industry, Alkem's journey began with a vision to transform India's healthcare landscape. Today, the company has established its presence in over 40 countries, operating 19 state-of-the-art manufacturing facilities and driving innovation through a team of 500+ scientists. Backed by a robust portfolio of 800+ brands, Alkem continues to set industry benchmarks in research, development, and manufacturing excellence. Alkem primarily focuses on developing medications for a wide range of therapeutic areas, including infectious diseases, gastrointestinal disorders, pain management, gynecological conditions, pediatrics, osteoporosis, arthritis, cardiovascular diseases, diabetes, and several other critical health concerns.


Company

[edit]

Alkem set up its research and development facility for ANDA development at Taloja in 2003.[4] In 2006 anti-infective drug Taxim of Alkem became the first anti-infective drug in the Indian pharmaceutical industry to cross 1,000 million in terms of domestic sales in India.[5] In 2014 Clavam another drug from Alkem crossed 2,000 million mark in terms of domestic sales in India.

In 2007 the company filed its first ANDA for drug Amlodipine which was approved in 2009.[4] Alkem has developed a portfolio of 705 branded generic drugs, with 13 of the brands featured among the top 300 brands in India for the fiscal year 2015 and a portfolio of 705 brands in India in the six months ended 30 September 2015. Alkem have 21 manufacturing facilities, 19 in India and 2 in US. 5 of the facilities are US FDA, TGA, UK MHRA approved.

Acquisitions

[edit]

Alkem has 21 manufacturing facilities: 19 in India and 2 in the US.[6] These 2 facilities in the US were acquired in 2012 and 2013 respectively. In 2014, Alkem acquired the "Clindac-A" brand in India from Galderma S.A. In 2015, Alkem acquired a formulation manufacturing facility in the US.[7]

Governance and administration

[edit]

Samprada Singh was the founder and chairman emeritus of the company, he led and shaped Alkem what it is today, he had a B.Com. degree from Patna University. He was the 42nd richest person in India and a billionaire.[8] His brother, Basudeo Narayan Singh,[9] was also the co-founder of the company. Samprada Singh died on 27 July 2019 at the age of 94 years after a brief illness in Mumbai.[10]

As per Forbes list of India's 100 richest tycoons, dated 9 October 2024, Singh family is ranked 41st with a net worth of $7.1 Billion.[11]

Position Name
Founder Chairman Emeritus Mr. Samprada Singh
Executive Chairman Mr. Basudeo Narayan Singh
Managing Director Mr. Sandeep Singh
Executive Director Mr. Mritunjay Kumar Singh
Executive Director Mrs. Madhurima Singh
Executive Director Mr. Sarvesh Singh
Executive Director Mr. Srinivas Singh
Independent Director Mr. Arun Kumar Purwar
Independent Director Mr. Narendra K Aneja
Independent Director Ms. Sangeeta Singh
Independent Director Ms. Sudha Ravi
Independent Director Mr. Sujjain Talwar
Independent Director Mr. Rajeev Kher[12]

References

[edit]
  1. ^ "List of Top Largest Pharmaceutical Companies in India [Updated 2022-2023]". Edudwar. 6 May 2022. Retrieved 31 May 2022.
  2. ^ a b c d e f "Alkem Laboratories Limited Annual Report 2024" (PDF). Alkem Laboratories Limited. Retrieved 2 July 2020.
  3. ^ https://www.alkemlabs.com/investors/subsidiary-accounts
  4. ^ a b "Alkem Laboratories Ltd. (ALKEM) – Company History". Business Standard India. Retrieved 31 May 2022.
  5. ^ "Alkem Laboratories History | Alkem Laboratories Information". The Economic Times. Retrieved 31 May 2022.
  6. ^ "List of Top Largest Pharmaceutical Companies in India [Updated 2022-2023]". Edudwar. 6 May 2022. Retrieved 31 May 2022.
  7. ^ Balakrishnan, Reghu (25 November 2015). "Alkem plans to double US revenue by 2020, launch IPO in December". mint. Retrieved 31 May 2022.
  8. ^ "Samprada Singh & family". Forbes.
  9. ^ "Basudeo Singh". Bloomberg.
  10. ^ "Alkem Labs Founder Samprada Singh passes away at the age of 92 years". Medical Dialogues. 27 July 2019.
  11. ^ "India's 100 Richest". India’s 100 Richest. 9 October 2024.
  12. ^ "Board of Directors". Alkem.
[edit]


Stub icon 1 Stub icon 2

This article about an Indian company is a stub. You can help Wikipedia by expanding it.

Retrieved from "http://en.wiki.x.io/w/index.php?title=Alkem_Laboratories&oldid=1276343732"